Mechanistically, mitochondria-targeted antioxidant treatment prevented the aggravation of cardiac hypertrophy in SIRT4-overexpressing mice, suggesting increased mitochondrial oxidative stress as the cause. This evidence concerns the gene SIRT4 and cardiac hypertrophy.